Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionRole of oxidants in interstitial lung diseases: pneumoconioses, constrictive bronchiolitis, and chronic tropical pulmonary eosinophiliaSystematic review and meta-analysis of hepatitis C virus infection and HIV viral load: new insights into epidemiologic synergyHIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis.Coordinated regulation of SIV replication and immune responses in the CNS.Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression.A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.Host hindrance to HIV-1 replication in monocytes and macrophages.Expression patterns and action analysis of genes associated with physiological responses during rat liver regeneration: Innate immune responseStromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophagesMEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma.Oral infectious diseases: a potential risk factor for HIV virus recrudescence?Neuropathogenic SIVsmmFGb genetic diversity and selection-induced tissue-specific compartmentalization during chronic infection and temporal evolution of viral genes in lymphoid tissues and regions of the central nervous system.Neutrophils activate alveolar macrophages by producing caspase-6-mediated cleavage of IL-1 receptor-associated kinase-MRegulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway.A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activationEarly emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivityMicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response.Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.Candida albicans delays HIV-1 replication in macrophages.HIV-1 and bacterial pneumonia in the era of antiretroviral therapy.Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patientsHigh-throughput transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium abscessus Smooth and Rough variants.CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection.Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.CCAAT/enhancer binding protein beta is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaquesErythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbetaDeployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentInterleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophagesCCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases.Acholeplasma laidlawii up-regulates granulysin gene expression via transcription factor activator protein-1 in a human monocytic cell line, THP-1.Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1.The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4.Evidence for a different susceptibility of primate lentiviruses to type I interferons.Inhibition of HIV-1 replication in alveolar macrophages by adenovirus gene transfer vectors.The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.
P2860
Q24550678-6D124535-4175-4F6D-942B-14F0EE6A7A29Q26824848-825521C4-5F2D-4354-8BA5-6B7FC64DD605Q28077305-613B7857-B4DE-41F9-8803-EC50C8038FB0Q33476859-EB8A7A72-9635-4D29-8CAC-B1F592340A02Q33519523-2720C8E0-A062-4369-8E64-D3BD11B69969Q33593821-7CB40AA0-8C33-4746-9B3F-AB199AB643F5Q33613718-DCC27069-69B9-4B12-A301-B80390357907Q33846376-5ACBD29B-3670-4E82-A0DB-801AF78F6A5FQ33866749-79CAA9DC-B04A-494F-BD96-F00773A01FE4Q33921277-51BF6ED4-036E-4922-803A-25782779DC6FQ34030536-323D3B2F-D93C-4FE0-882A-A7080305DA31Q34038531-A5632AE3-2B37-471E-9EDC-D4701F1B29D4Q34100200-0AF3BE8A-8CF8-48CA-ADF5-671AA30BD6BCQ34151363-94C8A71F-10CF-44FB-A5DF-2F4AAFB7A2E7Q34229621-83722E06-F7A0-4BAE-B417-B9C0FF38A3FCQ34356962-4077FF28-DAD9-4070-8B5B-C68E78736B47Q34404828-71C1C08B-370F-4CB1-ACBE-7AE55C9EF7BFQ34793627-0D210E56-9D44-490D-92DF-91EA1F417103Q34851055-8C1A9656-95FB-4768-AAD8-539D525AA6CDQ34979635-3DD16C30-3385-4AB3-9633-9CE94B569F26Q35095031-A6A5C4BA-EF22-48F6-B127-2E34BADF5B38Q35188470-1295A21E-2B76-4049-B59A-659CC4AE6306Q35799435-D9732741-F783-422D-A65B-E8C09D61178BQ35865474-A43D0BA2-3598-489D-A54C-A532748F9792Q36371384-9500FF06-702C-4AE0-A55C-7184AA13498CQ36575459-415B34CC-FD7C-4FCB-949F-571B8F9FEE8DQ36734869-8B3811CC-B872-4C3F-9A9E-C3CF6850AF88Q36858639-648CB6C6-D5AF-412E-B408-21E936E4D387Q37127522-2D5A50BF-4264-451F-8C8D-36D83EC0231CQ37273948-F80B14C9-3EFF-44DA-9D47-6ADB14661721Q37425262-F681A7B9-51D2-432A-A827-C11A6A5E3A60Q37848593-DB409272-2983-4293-B705-EDEACA57E1D1Q38294441-9C116231-4B2A-4DF4-864D-99E9CE1FA2CDQ38360283-60C6562C-4E42-41CE-9CA5-8D1A1A3C708BQ39030295-7684C950-1109-4C13-81E1-3268BA8B5E19Q39223017-6015300E-AE7A-4E38-9144-50B0836C175CQ39396705-9B4215D9-66B7-4340-AD89-6BCBFF84C444Q39592915-B003A8EC-FE20-4A3B-8130-E70840CA245DQ39604381-17CD226A-EEA3-4989-B0BE-4142B0B763C9Q39655236-C55F919C-A840-46B6-A4D9-3EC5F40D43CC
P2860
Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@ast
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@en
type
label
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@ast
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@en
prefLabel
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@ast
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@en
P2093
P2860
P921
P356
P1476
Type I interferon induces inhi ...... , enhancing HIV-1 replication.
@en
P2093
P2860
P304
P356
10.1084/JEM.188.7.1255
P407
P577
1998-10-01T00:00:00Z